- 737
- 552 604
PeerView Oncology
Registrace 13. 09. 2016
PeerView’s mission is to improve the knowledge, skills, and strategies that support clinical performance and patient outcomes via the provision of live and on-demand continuing education.
Advancing Immunotherapy in Cervical Cancer Care
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.
For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/YQP865. CME/MOC credit will be available until August 25, 2025.
Advancing Immunotherapy: Revolutionizing Cervical Cancer Treatment
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an educational grant from Merck & Co., Inc.
Disclosure information is available at the beginning of the video presentation.
For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/YQP865. CME/MOC credit will be available until August 25, 2025.
Advancing Immunotherapy: Revolutionizing Cervical Cancer Treatment
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an educational grant from Merck & Co., Inc.
Disclosure information is available at the beginning of the video presentation.
zhlédnutí: 112
Video
Mapping a New Treatment Journey in NF1
zhlédnutí 59Před 9 hodinami
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/DET865. CME/AAPA credit will be available until August 21, 2025. ...
Renovating Frontline Care for Metastatic Melanoma
zhlédnutí 149Před dnem
Hussein Tawbi, MD, PhD - Renovating Frontline Care for Metastatic Melanoma: Guidance on Upgrading to Combination Immunotherapy Standards Across Disease Presentations This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids,...
Optimal SCLC Care With Established and Innovative Therapies
zhlédnutí 308Před měsícem
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/HXN865. CME/MOC/NCPD/AAPA/IPCE credit will be avail...
Multidirectional HCC Tactics: Expert Guidance on Emerging Trends With Systemic Therapy Options
zhlédnutí 227Před měsícem
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/VXT865. CME/MOC/NCPD/AAPA/IPCE credit will be avail...
Clotting the Gaps in VWD Care
zhlédnutí 134Před měsícem
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/IPCE information, and to apply for credit, please visit us at PeerView.com/GXU865. CME/MOC/NCPD/IPCE credit will be available until...
Transforming MCL Management Guidance on Selecting and Using BTKi Platforms as First Line Therapy
zhlédnutí 144Před měsícem
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/QHV865. CME/MOC credit will be available until July 17, 2025. Step...
Innovation in CLL The Practicalities and Potential of Finite Therapy With BTKi Platforms
zhlédnutí 139Před měsícem
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/UFU865. CME/MOC credit will be available until July 15, 2025. Open...
Candid Conversations on Modern Urothelial Cancer Management
zhlédnutí 257Před měsícem
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/GJT865. CME/MOC/NCPD/AAPA/IPCE credit will be avail...
Unleashing the Innovation Era in AML
zhlédnutí 185Před měsícem
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YGR865. CME/MOC/NCPD/AAPA/IPCE credit will be avail...
Advances in Endometrial Carcinoma Treatment: The Power of Immunotherapy and Other Emerging Regimens
zhlédnutí 434Před měsícem
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RZJ865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 27, 2025. Na...
Illuminating the Path With Immunotherapy for Metastatic, Locally Advanced, and Early Stage NSCLC
zhlédnutí 254Před měsícem
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZUT865. CME/MOC/NCPD/AAPA/IPCE credit will be avail...
Three Rs for Modern Myeloma Care
zhlédnutí 101Před měsícem
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/VRK865. CME/MOC/AAPA/IPCE credit will be available until...
On Target: Using Trop-2-Directed Therapeutics for Urothelial Carcinoma
zhlédnutí 176Před měsícem
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZDU865. CME/NCPD/AAPA/IPCE credit will be available unt...
Expanding Frontline Frontiers in Multiple Myeloma Care
zhlédnutí 98Před měsícem
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/QTT865. CME credit will be available until July 18, 2025. Expanding Fr...
Decoding Biomarker Testing and Targeted Therapy in NSCLC
zhlédnutí 397Před 2 měsíci
Decoding Biomarker Testing and Targeted Therapy in NSCLC
Maximizing the Role of ADCs in Urothelial Carcinoma
zhlédnutí 134Před 2 měsíci
Maximizing the Role of ADCs in Urothelial Carcinoma
Unlocking the Power of Modern Therapeutic Regimens for Prostate Cancer
zhlédnutí 766Před 2 měsíci
Unlocking the Power of Modern Therapeutic Regimens for Prostate Cancer
Capitalizing on HER2-Targeted Regimens to Improve Outcomes for Gastric/GEJ Cancers, CRC, and BTC
zhlédnutí 321Před 2 měsíci
Capitalizing on HER2-Targeted Regimens to Improve Outcomes for Gastric/GEJ Cancers, CRC, and BTC
Catalysts for Change in Gastric & GEJ Cancer
zhlédnutí 335Před 2 měsíci
Catalysts for Change in Gastric & GEJ Cancer
HR+, HER2 , High Risk EBC A Practical Roadmap for CDK4 6 Inhibition in the Adjuvant Setting
zhlédnutí 379Před 2 měsíci
HR , HER2 , High Risk EBC A Practical Roadmap for CDK4 6 Inhibition in the Adjuvant Setting
Overcoming BTK Resistance With Non-Covalent BTKi
zhlédnutí 153Před 2 měsíci
Overcoming BTK Resistance With Non-Covalent BTKi
The Collaborative Benchmark for HCC: Critical Discussions Between IR-Oncology Professionals
zhlédnutí 380Před 2 měsíci
The Collaborative Benchmark for HCC: Critical Discussions Between IR-Oncology Professionals
Five Steps for Integrating BCMA Bispecific Innovations: Clinical Data to Clinical Practice in RRMM
zhlédnutí 95Před 2 měsíci
Five Steps for Integrating BCMA Bispecific Innovations: Clinical Data to Clinical Practice in RRMM
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable NSCLC
zhlédnutí 447Před 3 měsíci
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable NSCLC
Pharmacy Takes on Navigating the Therapeutic Landscape for Endometrial & Cervical Cancers
zhlédnutí 108Před 3 měsíci
Pharmacy Takes on Navigating the Therapeutic Landscape for Endometrial & Cervical Cancers
Modern Team-Based Therapeutic Management for Bladder Cancer Care
zhlédnutí 167Před 3 měsíci
Modern Team-Based Therapeutic Management for Bladder Cancer Care
Striking Back at ALL With Antibody Regimens
zhlédnutí 150Před 3 měsíci
Striking Back at ALL With Antibody Regimens
Harnessing Innovation in Bladder Cancer Care
zhlédnutí 217Před 3 měsíci
Harnessing Innovation in Bladder Cancer Care